Venous access pain. Pain, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: Each of the samples in the next dialysis session (two days later) randomly receives one of the following interventions: a vapocoolant spray, 10% lidocaine spray and
Sponsors
Bojnourd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: GCS 15 Ability to speak and understand Farsi or having Persian language translator Not have pacemaker Not have Known cardiac disease Start hemodialysis at least 3 months ago Not have Known reaction to lidocaine Products Not have damaged skin Not analgesic use in the last 24 hours Not use of the cream or products lidocaine in the past Hemodialysis via arteriovenous fistula Not anti arrhythmic medications use (especially Class 3 for example Amiodarone) Perform dialysis three times a week age more than 18 age less than 80
Exclusion criteria
Exclusion criteria: Skin reaction or abnormal response in arteriovenous fistula site Absence to perform hemodialysis Failure in vascular access by first try at any of the stages
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score. Timepoint: At the beginning of study, two days after, two weeks after the first intervention, four weeks after the first intervention and six weeks after the first intervention. Method of measurement: Numerical Rating Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSima Sadat Hejazi
Bojnourd University of Medical Sciences
Outcome results
None listed